CORONA Remedies Ltd
NSE: CORONA | BSE: 544644
₹1,781.80
As on 19-May-2026IST
Market cap
₹10,893 Cr
Revenue (TTM)
₹1,196 Cr
P/E Ratio
58.8
P/B Ratio
14.6
Div. Yield
0.6 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
1/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹149 Cr
-
ROE
27.5 %
-
ROCE
32.6 %
-
Industry P/E
26.81
-
EV/EBITDA
36.1
-
Debt to Equity
0.1
-
Book Value
₹99.1
-
EPS
₹24.4
-
Face value
10
-
Shares outstanding
61,160,088
5 Years Aggregate
CFO
₹221.86 Cr
EBITDA
₹645.89 Cr
Net Profit
₹394.41 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CORONA Remedies
| 28.7 | 10.0 | 12.2 | -- | -- | -- | -- |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CORONA Remedies
|
1,781.8 | 10,892.9 | 1,196.4 | 149.4 | -- | 27.5 | 58.8 | 14.6 |
| 3,248.2 | 40,546.6 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38.4 | 9.0 | |
| 8,695.5 | 21,719.0 | 2,177.5 | 200.9 | 11.3 | 26.5 | 108.1 | 26.1 | |
| 2,038.2 | 15,490.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.2 | 4.3 | |
| 1,336.2 | 18,531.3 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.9 | 5.1 | |
| 2,171.6 | 34,908.7 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.2 | 8.4 | |
| 4,785.4 | 21,859.4 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.3 | 5.2 | |
| 5,340.5 | 8,874.7 | 1,348.5 | 293.5 | 28.1 | 50.7 | 30.2 | 12.7 | |
| 472.5 | 9,248.1 | 1,432.0 | 149.0 | 19.1 | 7.9 | 61.6 | 3.7 | |
| 1,153.6 | 10,633.5 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsAbout CORONA Remedies
--
-
Incorporated
2004
-
Chairman
Kirtikumar Laxmidas Mehta
-
Managing Director
Niravkumar Kirtikumar Mehta
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about CORONA Remedies Ltd’s IPO? Explore our IPO Details page.
Quarterly Updates
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
11-May-2026No News & Announcements are available.
FAQs for CORONA Remedies
What is the current share price of CORONA Remedies Ltd Today?
The share price of CORONA Remedies Ltd is ₹1,781.80 (NSE) and ₹1,781.05 (BSE) as of 19-May-2026 IST. CORONA Remedies Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of CORONA Remedies Ltd?
The P/E ratio of CORONA Remedies Ltd is 58.84 times as on 19-May-2026, a 119 premium to its peers’ median range of 26.81 times.
The P/B ratio of CORONA Remedies Ltd is 14.59 times as on 19-May-2026, a 214 premium to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of CORONA Remedies Ltd?
The 52-week high and low of CORONA Remedies Ltd are Rs 1,949.40 and Rs 1,336.60 as of 20-May-2026.
What is the market cap of CORONA Remedies Ltd?
CORONA Remedies Ltd has a market capitalisation of ₹ 10,893 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in CORONA Remedies Ltd?
Before investing in CORONA Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
